ArticleJournal of managed care & specialty pharmacy2025
Pediatric-onset rare disease therapy pipeline yields hope for some and gaps for many: 10-year projection of approvals, treated patients, and list price revenues.
Colin M Young et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.